Cormedix INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
CRMD
Cormedix INCCorMedix Inc. is holding its 2026 Annual Meeting of Stockholders on June 23, 2026, to vote on several proposals, including director elections, executive compensation, auditor ratification, and significant amendments to its corporate charter and preferred stock designations.
NASDAQ
CRMD
Cormedix INCDEF: CorMedix Seeks Shareholder Approval for Key Governance, Equity, and Acquisition-Related Proposals
CorMedix Inc. calls a Special Meeting on November 10, 2025, to vote on critical proposals including removing an exchange cap for convertible notes and an acquisition, increasing its stock incentive plan, and ratifying past preferred stock amendments.
NASDAQ
CRMD
Cormedix INCCormedix Inc. announces its 2025 Annual Meeting of Stockholders to be held on June 24, 2025, outlining key voting items including the election of directors, executive compensation, and the ratification of the company's accounting firm.
NASDAQ
CRMD
Cormedix INCCorMedix Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 24, 2025, to elect directors, approve executive compensation, and ratify the appointment of its independent accounting firm.
NASDAQ
CRMD
Cormedix INCCorMedix Inc. will conduct its 2024 Annual Meeting of Stockholders virtually on November 21, 2024, to vote on key proposals including the election of directors and an amendment to the stock incentive plan.